Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,398 across all filing types
Latest filing 2018-06-12 Investor Presentation
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
Goldman Sachs 39th Annual Global Healthcare Conference
Investor Presentation Classification · 100% confidence The document is a slide deck titled 'Goldman Sachs Annual Global Healthcare Conference' dated June 2018. It contains detailed financial performance metrics, business segment analysis, market dynamics, and forward-looking guidance for Fresenius. It is clearly a presentation prepared for an investor conference, which aligns with the definition of an Investor Presentation (IP). Q1 2018
2018-06-12 English
Deutsche Bank – dbAccess Berlin Conference
Investor Presentation Classification · 98% confidence The document text is a presentation titled "dbAccess Berlin Conference" dated June 06, 2018. It contains detailed financial performance data, segment reviews (Fresenius Medical Care, Kabi, Helios, Vamed), financial outlooks for FY/18, and Q1/18 actual results, including P&L statements and growth rates. The content is highly detailed, covering strategy, market dynamics, and specific financial guidance, which is characteristic of an Investor Presentation (IP) or a detailed Management Discussion and Analysis (MDA) often presented at investor conferences. Since it is explicitly presented at a conference and contains forward-looking statements and detailed segment breakdowns typical of investor outreach, 'Investor Presentation' (IP) is the most appropriate classification. It is too detailed to be a simple Earnings Release (ER) and is not the full annual report (10-K) or a standalone interim report (IR), but rather a presentation summarizing these results.
2018-06-06 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Total Voting Rights Announcement' and explicitly mentions the 'Publication of total number of voting rights' as of May 31, 2018. It details a 'Type of capital measure' which is a 'Conditional capital increase' and states the 'New total number of voting rights'. This type of mandatory disclosure regarding changes in the total number of shares/voting rights, often triggered by capital structure events, fits best under Capital/Financing Update (CAP) or potentially a general Regulatory Filing (RNS). Since it specifically concerns a capital measure (conditional capital increase) and the resulting voting rights count, CAP is the most precise fit among the defined categories. It is not a full report (10-K, IR), an earnings release (ER), or a dividend notice (DIV).
2018-05-31 English
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'DGAP-DD: Fresenius SE & Co. KGaA english' and contains the header 'Directors’ Dealings'. The content details transactions (exercise of options and sale of shares) by a person discharging managerial responsibilities (Mats Henriksson, Member of the managing body). This directly corresponds to the definition of Director's Dealing reports.
2018-05-23 English
Hauptversammlung 2018, Fresenius
AGM Information Classification · 99% confidence The document text is titled "Hauptversammlung – Fresenius SE & Co. KGaA" and dated May 18, 2018. It contains key performance indicators for the year 2017, highlights of business segments, dividend proposals, and outlook statements. The term 'Hauptversammlung' translates to Annual General Meeting (AGM). The content strongly suggests presentation materials used or shared during this meeting, rather than a formal regulatory filing like a 10-K or an Earnings Release (ER). Therefore, it fits the definition of AGM Information.
2018-05-18 German
Declaration of Voting Results & Voting Rights Announcements 2018
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Notification of Major Holdings' under German securities law (WpHG). It details the acquisition/disposal of shares and instruments, crossing a threshold (5.002% voting rights) by Allianz Global Investors GmbH. This type of filing, reporting changes in significant share ownership, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although the header mentions 'Voting Rights Announcements', the content is a specific notification of a major holding change, which is best classified as MRQ.
2018-05-16 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.